| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |